AKI Management Using Electronic Alerts

Overview

Acute kidney injury (AKI) is a common clinical event with severe consequences. In the United States alone, greater than one million hospitalized patients per year are diagnosed with AKI. It has been independently associated with prolonged hospital stays, 25-80% risk of in-hospital death, and future progression to chronic kidney disease. While there has been an increase in awareness about the prevalence and significance of AKI, studies have uncovered systematic failure in the management of AKI, largely relating to the failure of clinicians to recognize and manage the condition appropriately. This is where we can use electronic health records (EHRs) and electronic alerts (e-alerts) to our advantage. In this study, the investigators plan to use e-alerts integrated into a clinical decision support (CDS) system to improve the care of and outcomes of patients with AKI. The aims are to study the prevalence of AKI and its progression among hospitalized patients using an 'AKI sniffer' (an EHR based automated system) and to prospectively study if introducing a complex intervention (an e-alert combined with a clinical decision support system) will reduce progression of AKI in children. The investigators have developed an AKI care bundle which provides simple guidelines for management of AKI along with specific discharge instructions to improve follow up care. The primary outcome is AKI progression. Secondary outcomes include morbidity, mortality, length of hospital stay, need for renal replacement therapy, and recovery of renal function by time of hospital discharge. The investigators will also look at documentation of AKI and if these participants get appropriate follow up.

Full Title of Study: “Acute Kidney Injury: Integrating E-alerts and Clinical Decision Support System to Improve Outcomes”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 16, 2018

Interventions

  • Other: electronic alert and clinical decision support system
    • Providers taking care of patients will receive an electronic alert and will be guided to use a clinical decision support system

Arms, Groups and Cohorts

  • No Intervention: Baseline group
    • This will be the pre and post alert phase where e-alerts will not be sent to providers
  • Other: Alert group
    • This will be the phase when e-alerts will be sent to the provider

Clinical Trial Outcome Measures

Primary Measures

  • AKI documentation
    • Time Frame: 28 days
    • Documentation of AKI in progress notes and discharge summary

Secondary Measures

  • AKI progression
    • Time Frame: 7 days
    • Progression of AKI from Stage 1 to Stage 2/3

Participating in This Clinical Trial

Inclusion Criteria

All patients between 6 months-18 years admitted to the surgical and medical floors of Seattle Children's Hospital Exclusion Criteria:

1. History of chronic kidney disease stage 4 or worse (i.e., patients on chronic renal replacement therapy or glomerular filtration rate < 30 mL/min/1.73 m2) 2. History of renal transplantation within the last 3 months 3. History of nephrectomy within last 3 months 4. Patients admitted to observation units

Gender Eligibility: All

Minimum Age: 6 Months

Maximum Age: 18 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Seattle Children’s Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Shina Menon, Assistant Professor – Seattle Children’s Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.